More GEN Content From This Contributor

• Columns: Hotspots of miRNA Research Activity
• Columns: Granular Look at Stem Cell Research
• Columns: Cellular Therapy Wave Finally Cresting
• Columns: Cancer Biomarker Hotspot Analysis
• Columns: En Bloc Analysis of Epigenetic Publications
• Columns: Rise of Cell-Based Immunotherapy
• Market and Technology Analysis: Eye on Single-Cell Analysis
• Market and Technology Analysis: Epigenetic Research Classes and Assay Trends
• Market and Technology Analysis: Eye on Next-Generation Sequencing
• Market and Technology Analysis: Eye on Cancer Biomarkers
• Market and Technology Analysis: Cancer Biomarkers: Your Questions Answered
• Market and Technology Analysis: Eye on Cord Blood for Cell Therapy
• Market and Technology Analysis: Stem Cells in the EU: Northern and Central Markets
• Columns: Cord Blood for Cellular Therapy
• Market and Technology Analysis: Exosomes Market Snapshot
• Market and Technology Analysis: Eye on MicroRNA Associations and Signatures
• Market and Technology Analysis: Long Noncoding RNAs: Why You Need to Know about Them Now
• Market and Technology Analysis: Epigenetic Signatures Landscape
• Market and Technology Analysis: Biomarker Trajectories: Molecular Entities and Their Progression as Biomarkers
• Market and Technology Analysis: What You Need to Know about Advanced Therapy Medicinal Products
• Market and Technology Analysis: Stem Cell Market: A Rapidly Expanding Field Ripe with Opportunities
• Market and Technology Analysis: lncRNAs and Epigenetic Modulations: Potential Hotspots
• Market and Technology Analysis: Growth Factors for Cell Culture
• Market and Technology Analysis: Next-Generation Sequencing from Research to the Clinic
• Market and Technology Analysis: Cancer Personalized Medicine: What You Need to Know
• Market and Technology Analysis: MicroRNA Therapeutics Heading Toward the Clinic
• Market and Technology Analysis: Cancer Stem Cells: Making Sense of the Data
• Market and Technology Analysis: China’s In Vitro Diagnostics Marketplace, Part I
• Market and Technology Analysis: Commercializing iPSCs: A Quantitative Snapshot
• Market and Technology Analysis: The Transfection Marketplace: What You Need to Know
• Market and Technology Analysis: Mass Spec Market Snapshot
• Market and Technology Analysis: Liquid Biopsies: An Area You Need to Watch
• Columns: miRNA Therapeutics Heading to the Clinic
• Market and Technology Analysis: Laboratory-Developed Tests Based on Mass Spec
• Market and Technology Analysis: Mass Spec Sample Prep and Multiplexing Trends
• Market and Technology Analysis: Next-Gen Sequencing Update
• Market and Technology Analysis: Single-Cell Analysis Answers Multiple Questions
• Market and Technology Analysis: Biomarkers: Two Hotspot Snapshots
• Columns: Surveying the Exosome Market Landscape
• Market and Technology Analysis: The Common Bonds between Cancer Classes
• Market and Technology Analysis: microRNAs and lncRNAs: Phenotype Links
• Market and Technology Analysis: DNA Methylations and Histone Modifications: Links to Diseases
• Market and Technology Analysis: Eye on Circulating Biomarkers
• Market and Technology Analysis: The Potential of Fat for Regenerative Medicine
• Market and Technology Analysis: Clinical Trials Focusing on Fat for Regenerative Medicine
• Market and Technology Analysis: Evolution of the Liquid Biopsies Space, Part I
• Market and Technology Analysis: The Utility of Fat for Regenerative Medicine
• Market and Technology Analysis: Point-of-Care Diagnostics Publications Analysis
• Market and Technology Analysis: Molecular Diagnostics Publications Analysis
• Market and Technology Analysis: Circulating Tumor Cells Publications Analysis
• Market and Technology Analysis: Next-Generation Sequencing Market Trends
• Market and Technology Analysis: Mass Spectrometry: Transition from Research to Clinic
• Market and Technology Analysis: NGS and Cancer Biomarker Market Metrics
• Market and Technology Analysis: Epigenetics Market Trends
• Market and Technology Analysis: microRNA Temporal Associations
• Market and Technology Analysis: Cord Blood Market Trends
• Market and Technology Analysis: lncRNA Market Trends
• Market and Technology Analysis: Personalized Medicine Market Trends, Part I
• Market and Technology Analysis: Personalized Medicine Market Trends, Part II
• Market and Technology Analysis: Epigenetic Biomarkers and Clinical Trials
• Market and Technology Analysis: POC Diagnostics in the Cardiovascular Disease Space
• Market and Technology Analysis: Cancer Stem Cells: An Elusive Target
• Market and Technology Analysis: The In Vivo and In Vitro Transfection Marketplace
• Market and Technology Analysis: Eye on Point-of-Care Diagnostics
• Market and Technology Analysis: Cord Blood Marketplace Update
• Market and Technology Analysis: Prognostic vs. Predictive Biomarkers Landscape
• Market and Technology Analysis: China IVD Marketplace, Part II—Companies in the Space
• Market and Technology Analysis: microRNAs as Biomarkers
• Market and Technology Analysis: Circulating Biomarkers Industry Landscape
• Market and Technology Analysis: NGS Market Survey Frames the Landscape from the Bottom-Up
• Market and Technology Analysis: Tissue Engineering: Framing the Landscape, Part I
• Market and Technology Analysis: Tissue Engineering: Framing the Landscape, Part II
• Market and Technology Analysis: Mass Spectometry in Clinical Diagnostics
• Feature Articles: GEN Roundup: Snapshot of the Extracellular Vesicles (EVs) Market Landscape
• Market and Technology Analysis: Biofluid Biopsies Utilizing Circulating Biomarkers
• Market and Technology Analysis: Exosomes Market Dynamics
• Market and Technology Analysis: Single Cell Analysis (SCA): Market Trajectory
• Market and Technology Analysis: The Genome Engineering Landscape—A Complete Analysis of Publications, Part I
• Market and Technology Analysis: Lab-on-a-Chip Market Dynamics
• Market and Technology Analysis: Market Dynamics of the Point-of-Care Diagnostics (POCD) Field
• Market and Technology Analysis: Biofluid-Based Biopsies
• Market and Technology Analysis: Point-of-Care Diagnostics: Market Dynamics, Part II
• Market and Technology Analysis: Evolution of MicroRNA Research Over the Past Decade
• Market and Technology Analysis: Single Cell Analysis (SCA) Market Dynamics, Part II
• Market and Technology Analysis: Exosome Market Dynamics, Part I
• Market and Technology Analysis: Exosome Market Dynamics, Part II
• Market and Technology Analysis: Exosome Market Dynamics, Part III
• Market and Technology Analysis: Bioprinting Market Dynamics
• Market and Technology Analysis: Liquid Biopsies
• Market and Technology Analysis: Analysis of the RNA-Seq and SCA Publication Landscape
• Market and Technology Analysis: Point-of-Care Diagnostics—An Expanding Field Driven by Technology Development
• Market and Technology Analysis: Liquid Biopsies Landscape
• Market and Technology Analysis: Microfluidics in the Life Sciences
• Market and Technology Analysis: The Cancer Biomarkers Marketplace
• Market and Technology Analysis: Cancer Immunotherapy 2016
• Market and Technology Analysis: The Evolution of the Glycobiology Space
• Market and Technology Analysis: The Impact of Microfluidics, Lab-on-a-Chip Technologies on the Development of the POC Dx Markets
• Market and Technology Analysis: A 10,000-Foot View of the Stem Cell Market Landscape
• Market and Technology Analysis: Epigenetics Market Landscape: A Qualitative and Quantitative Picture
• Market and Technology Analysis: Evolution of the Exosomes Market Landscape
• Market and Technology Analysis: Trends in Various Segments of the Circulating Biomarkers Space